Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arch Therapeutics Inc (ARTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 56,065
  • Shares Outstanding, K 172,562
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,810 K
  • 60-Month Beta 0.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/20/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2600 +24.96%
on 05/30/19
0.3750 -13.36%
on 06/10/19
+0.0359 (+12.42%)
since 05/17/19
3-Month
0.2600 +24.96%
on 05/30/19
0.4300 -24.44%
on 05/01/19
-0.0551 (-14.50%)
since 03/18/19
52-Week
0.2600 +24.96%
on 05/30/19
0.6900 -52.91%
on 06/28/18
-0.1151 (-26.16%)
since 06/18/18

Most Recent Stories

More News
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering

Arch Therapeutics, Inc. (OTCQB: ARTH)("Arch" or the "Company"), a developer of novel liquid, gel and solid hemostatic and wound care devices, today announced the pricing of registered direct offering of...

ARTH : 0.3249 (-4.44%)
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of products for dermal science and biosurgical applications, today announced that the company will attend The Symposium on Advanced...

ARTH : 0.3249 (-4.44%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7380 (-0.27%)
TRLFF : 0.3368 (-2.38%)
AITB : 5.65 (+7.62%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.1000 (unch)
ATEA : 5.5000 (+0.34%)
CWBHF : 12.8900 (+7.94%)
CVSI : 4.1050 (-1.32%)
DUOT : 0.8500 (unch)
CRLBF : 10.7500 (+5.39%)
ARREF : 0.4877 (+2.98%)
CLOK : 0.9499 (-1.05%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.2800 (+0.36%)
HEOFF : 0.9100 (-4.11%)
MJARF : 0.8901 (-4.80%)
ALEAF : 0.9460 (-0.42%)
OTCM : 32.3000 (+2.54%)
NUPMF : 1.5613 (-1.81%)
GLDLF : 0.6500 (-0.47%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3375 (+2.27%)
GBPT : 0.3000 (+5.93%)
IMLFF : 0.2500 (-3.74%)
KSHB : 4.3375 (-1.42%)
CORVF : 1.5700 (+1.95%)
ELLXF : 2.6450 (-2.40%)
RSSS : 2.3000 (unch)
ISYRF : 0.9150 (+4.21%)
FLUX : 1.0200 (-6.42%)
NWGI : 0.3175 (+2.45%)
QBIO : 1.3200 (+2.33%)
WIZD : 0.1600 (unch)
MRMD : 2.2500 (+7.66%)
GRWG : 3.1200 (+0.65%)
BRTI : 0.1500 (-5.66%)
GTBP : 0.2800 (unch)
MRIC : 3.1900 (unch)
DYAI : 6.46 (+3.53%)
GTBIF : 10.1000 (-0.98%)
MTAFF : 0.7600 (-1.30%)
EMHTF : 2.0700 (+3.50%)
ITHUF : 3.3122 (-5.37%)
ALYE : 3.5000 (-12.50%)
VTLR : 0.1400 (unch)
ARHH : 1.2500 (+0.94%)
OWCP : 0.0140 (-4.76%)
STLHF : 0.5653 (-1.07%)
PPCB : 0.0076 (+5.56%)
ARTH : 0.3249 (-4.44%)
ACRGF : 19.0000 (unch)
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference

Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 31 Annual ROTH...

ARTH : 0.3249 (-4.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ARTH with:

Key Turning Points

2nd Resistance Point 0.3670
1st Resistance Point 0.3459
Last Price 0.3249
1st Support Level 0.3079
2nd Support Level 0.2910

See More

52-Week High 0.6900
Fibonacci 61.8% 0.5257
Fibonacci 50% 0.4750
Fibonacci 38.2% 0.4243
Last Price 0.3249
52-Week Low 0.2600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar